Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07210606
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT07210606
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07210606. Randomized; double masking; primary purpose treatment. Start 2026-09-16 (actual); primary completion 2030-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
- Acronym
- CSA-HF
- Condition
- Sleep Disordered Breathing
- Condition
- Able Bodied
- Intervention (Drug)
- Trazodone + positive airway pressure (PAP) therapy
- Intervention (Drug)
- Oxygen + positive airway pressure (PAP) therapy
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct07210606- Content hash
f64b7ea855fb163b2ad2b10685630db5fc0d23594c400c7d44df35019c475b40